Rocket Lab Rises 7% as Cantor Boosts Target

Rocket Lab jumps 7% after Cantor Fitzgerald reiterates $122 target on launch record, outpacing peers without catalysts.

By ·

Sep 21, 2026

7 cards · 1m · tap to begin

From · · · 1m

Rocket Lab Rises 7% as Cantor Boosts Target

Rocket Lab jumps 7% after Cantor Fitzgerald reiterates $122 target on launch record, outpacing peers without catalysts.

In brief

Rocket Lab jumps 7% after Cantor Fitzgerald reiterates $122 target on launch record, outpacing peers without catalysts. Rocket Lab's stock gained despite no new catalysts, as Cantor's reiteration of a target falls short of actual market moves. Originally reported by 24/7 Wall St..

Cantor Reiterates Target

Cantor Reiterates Target

Cantor Fitzgerald restated an Overweight rating and $122 price target for Rocket Lab shares.

“Cantor Fitzgerald reiterated its Overweight rating and a $122 price target on Rocket Lab shares.”

Rocket Lab Surges

Rocket Lab stock climbed 7% in Monday morning trading, outperforming the broader market.

“Rocket Lab stock is at $69.03, up 7% in Monday morning trading.”

Intuitive Machines Jumps

Intuitive Machines stock rose 10% without any research catalysts or announcements.

“Intuitive Machines stock is at $15.28, up 10% in Monday morning trading.”

AST SpaceMobile Rises

AST SpaceMobile stock increased 6% as part of a coordinated bid across space stocks.

“AST SpaceMobile stock is at $61.81, up 6%.”

Peer Group Outperformance

Intuitive Machines outperformed Rocket Lab despite no catalysts, indicating concentrated buying in space stocks.

“Intuitive Machines is up by more than Rocket Lab despite no catalysts.”

Cantor's Catalysts

Cantor expects Neutron's debut flight and Iridium Communications acquisition to move Rocket Lab stock.

“Cantor expects Neutron's debut flight and closing the pending Iridium Communications acquisition to move the stock.”

No Timeline for Catalysts

Neither Neutron's flight nor Iridium's acquisition has a confirmed timeline for execution.

“The note attached no timeline to either event, so the entry-point argument rests on catalysts nobody has committed to a date on.”

What matters most

Rocket Lab's stock gained despite no new catalysts, as Cantor's reiteration of a target falls short of actual market moves.

Read the original on 24/7 Wall St.

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on rocket lab and related topics.